Dexcom highlights new diabetes outcomes and product roadmap at ATTD 2026

Curatis and Neupharma partner to develop corticorelin for peritumoral brain edema in Japan

Citius Oncology reports positive topline results from Phase 1 clinical trial of LYMPHIR combination

GenomOncology partners with WeTrials to support CNS cancer clinical trials

Immunic granted European patent for vidofludimus calcium dosing regimens

Agenus triggers USD20m milestone payment under Zydus manufacturing collaboration

HeartBeam and Mount Sinai partner to advance AI-enabled cardiac monitoring

Medicomp Systems client IJN in Malaysia granted Stage 7 validation from HIMSS EMRAM

Biofrontera reports Phase 2b data for Ameluz photodynamic therapy in acne vulgaris treatment

Pfizer reports positive Phase 2 results for trispecific antibody in atopic dermatitis

Precision BioSciences receives FDA Fast Track designation for PBGENE-DMD

AstraZeneca and Daiichi Sankyo's Enhertu receives US priority review for post-neoadjuvant HER2-positive early breast cancer

Zelluna partners with Etcembly to advance AI-driven TCR engineering for solid tumours

IDEAYA Biosciences enrols first patient in Phase 1 trial of PRMT5 inhibitor IDE892

Kelun-Biotech and Harbour BioMed receive China IND approval for atopic dermatitis therapy